FDA Inspection
American Red Cross-Myrtle BeachAmerican Red Cross-Myrtle Beach – FDA Inspection, Oct 29, 2010
Record Details
This FDA Inspection record concerns American Red Cross-Myrtle Beach, with an inspection on October 29, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 29, 2010
- Product Type
- Biologics
View Company Profile
ID · e4380860-fe7a-461d-8131-a8572a56af2c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 696847
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross-Myrtle Beach
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 9, 2026 | Not classified | Atlanta District Office | |
| April 6, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 2, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 24, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross-Myrtle Beach
- FDA Inspection 1330826 - 2026-07-09
- FDA Inspection 1204031 - 2023-04-06
- FDA Inspection 1021137 - 2017-08-02
- FDA Inspection 931618 - 2015-06-24
- FDA Inspection 846755 - 2013-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.